Novel Biomaterials for Medical Applications

Investing in Creating and Acquiring Innovative IP Is Vital to Current Competitive Landscape

USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This Research Service (RS) offers a strategic perspective on the global emerging industry of biomaterial technologies for various medical applications. This research service is segmented into three chapters, with the first two focusing on analysis of the top trends from both technology and industry perspectives. The third chapter brings out the synergies for partnership initiative within the industry, reviewing the roles and strategies of both existing and emerging participants.Key Questions Answered by this RS:1. What is the role played by NPD (new product development) and R&D (research and development) initiatives in improving the overall adoption of biomaterials technologies across medical applications?2. Wh

Table of Contents

1.0 Executive Summary1.1 Scope of Research 1.2 Research Methodology 1.3 High Scope for Funding Research on Applications of PMMA, PEEK, and PLA1.4 Application of Biomaterials for Tissue Regeneration is an Actively Explored Area of Research Worldwide1.5 Success of Clinical Trials is Critical to Market Expansion Efforts of Leading Medical Technology Developers2.0 Technology Segmentation and Analysis2.1 Four Major Class of Biomaterials Constitute Over 90% of the Global Market for Medical Applications of Biomaterials2.2 The Magnitude of Clinical Applications of Biomaterials is Very High for Cardiovascular Applications, Followed by Orthopedic2.3 Global Technology Development Initiatives Focus on Enhancing Functional Aspects and Durability of Medical Implants2.4 Commercial Attractiveness and Intensity of IP for Applications of Polymeric Biomaterials is High2.5 Favorable Economical and Technical Impact of Biomaterials across Various Medical Applications Drive Global R&D Efforts2.6 Polyethylene, Titanium Alloys, Silicone Rubber are Most Widely Used Biomaterials in Fabrication of Clinically Effective Medical implants2.7 Growing Demand for Newer Classes of Biomaterials Push Product Development Efforts across the Asia Pacific Region2.8 3D Printing of Metals and Metal Alloys Enable Fabrication of Implants that Mimic Functions of Cancellous Bone Structures3.0 Global Technology Development Trends3.1 Clinical Trials Demonstrating Safety and Efficacy of Biomaterials Drive their Adoption across the Value Chain3.2 Hybrid Biomaterials that Combine Metals and Polymers Increase the Clinical Value of Medical Implants3.3 Demonstrating Clinical Value of Implants is Critical to Sustainable Adoption of Newer Classes of Biomaterials3.4 Metallic and Polymeric Biomaterials Exhibit High Potential for Investments from Venture Capital and Private Equity Firms3.5 Over 80% of Private Investments is Restricted to Technology Development and Clinical Evaluation of Biomaterials4.0 Key Recommendations to Industry Stakeholders4.1 Technologies Available for Licensing are Very High for the Clinical Application of Polymeric & Natural Biomaterials4.2 Diversification Efforts of Technology Developers Focus on Enhancing Effectiveness and Durability of Medical Implants4.3 Magnitude of In-house Scientific Research is Very High for Polymeric Biomaterials Despite Low Availability of Research Grants5.0 Patent Landscape Assessment5.1 The Ratio of Granted and Applied Patents Strike a Right Balance across Various Classes of Biomaterials Used in Medical Applications5.2 Spain and Germany are Jurisdictions with Key Patents Focusing on the Synthesis of Biomaterials for Tissue Regeneration Applications5.3 Cured-oil Hydrogel Biomaterials are Actively Explored as Effective Carriers in the Fabrication of Drug Delivery Systems5.4 3D Printing Techniques and Materials are Actively Explored by Academic Research Groups for Fabricating Medical Implants5.5 Key Contacts5.5 Key Contacts (continued)Legal Disclaimer6.0 The Frost & Sullivan Story6.1 The Frost & Sullivan Story6.2 Value Proposition: Future of Your Company & Career6.3 Global Perspective6.4 Industry Convergence6.5 360º Research Perspective6.6 Implementation Excellence6.7 Our Blue Ocean Strategy

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.